ImmunoSep aims at significantly improving the treatment outcome of sepsis through a precision-medicine approach that reflects the different manifestations of this severe clinical condition in individual patients.
Mission & Aims
The mission of ImmunoSep is to design and perform a proof-of-concept clinical trial of personalised immunotherapy in sepsis and, within this clinical trial, to develop a next-generation theranostics platform for the design of future personalised immunotherapy trials in sepsis.
“For the benefit of the patient, ImmunoSep will apply novel basic science principles to direct clinical practice. We therefore positioned the project at the intersection between cutting-edge science, translational and clinical programmes and social science integration in daily clinical practice. We are aiming to insure a rapid translation ‘from idea to application’ starting from basic molecular research to translational medicine and epidemiology.“Prof. Mihai Netea RadboudUMC,
Coordinator of ImmunoSep